IP Library Granted Patent US 9,255,336
Granted Patent B2
US 9,255,336 · App. 13/727,191 · Granted Feb 9, 2016

Method and apparatus for producing a stabilized antimicrobial non-toxic electrolyzed saline solution exhibiting potential as a therapeutic

Inventors: Verdis Norton (Sandy, UT); Gary L. Samuelson (Sandy, UT)
C25B15/02A61K33/00A61K33/14A61K33/20A61K33/40A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,255,336
App. No.
13/727,191
Granted
Feb 9, 2016
Kind
B2
Abstract

An improved method and apparatus for producing a stable, non-toxic, antimicrobial electrolyzed saline solution with a broad range of anti-infective and therapeutic applications. The resulting electrolyzed saline solution exhibits a marked lack of toxicity upon intravenous, aspired, oral or topical application in mammals for therapeutic applications providing a broad platform, including topical disinfection, antimicrobial application, wound treatment, oxidative stress reduction and enhancement of immune function to better detect malfunctioning cells.

Claims (29)

1. An apparatus for producing a stable, non-toxic, antimicrobial electrolyzed saline solution exhibiting anti-infective and immune-enhancing potential as a therapeutic containing regulated amounts of stable reactive oxygen species (ROS), comprising:

a) a container filled with a saline solution having a saline concentration of at least about 0.15%, the container comprising a single exterior opening that is fitted with a lid;

b) an inert anode and a spaced apart corresponding inert cathode placed within the saline solution;

c) a combination heating/cooling device disposed coaxially along an interior side of the container configured to exchange heat with the saline solution to maintain the saline solution at a desired temperature between 30° F. and 100° F. to prevent production of chlorates and to regulate relative concentrations of resulting components during electrolysis;

d) an exteriorly mounted circulation tube in fluid communication with a top and a bottom interior of the container configured with a pump to provide fluid circulation within the container to ensure complete mixing and electrolysis of the saline solution and a variation of less than 5% from batch to batch; and

e) a power source associated with the anode and cathode to apply an effective voltage potential less than about thirty volts between the cathode and the anode sufficient to produce a balanced mixture comprising one or more of Hypochlorous acid (HOCl), Hypochlorites (OCl − , NaClO), dissolved Oxygen (O 2 ), Chlorine (Cl 2 ) between 1 to 200 ppm, Hydrogen (H 2 ) gas, Hydrogen Peroxide (H 2 O 2 ), Hydrogen ions (H + ), Hypochloride (ClO), Superoxides (*O 2 − , HO 2 ), Ozone (O 3 ) between about 1 ppm and about 50 ppm, Activated Hydrogen ions (H − ), Chloride ions (Cl − ), Hydroxides (NaOH, OH − ), Singlet Oxygen (*O 2 ), *OCl, and *HO − , and wherein total ROS is between about 0.05 ppm and about 50 ppm, utilizing at least one of electron and proton donation, ion and dissolved-gas transport, the temperature, anode and cathode spacing, saline solution circulation rate, and effective voltage combination selected to achieve desired electrolysis efficiencies and stable specie compositions containing stable ROS compounds while preventing production of chlorates.

2. An apparatus for producing a stable, non-toxic, antimicrobial electrolyzed saline solution exhibiting anti-infective and immune-enhancing potential as a therapeutic containing regulated amounts of stable reactive oxygen species (ROS) according to claim 1 , wherein the container is fabricated from a biologically compatible material.

3. An apparatus for producing a stable, non-toxic, antimicrobial electrolyzed saline solution exhibiting anti-infective and immune-enhancing potential as a therapeutic containing regulated amounts of stable reactive oxygen species (ROS) according to claim 1 , wherein the anode is made of a base metal selected from the group consisting of platinum, niobium, titanium or any metal compatible with platinum bonding and is coated with an outer layer of platinum bonded to the base metal.

4. An apparatus for producing a stable, non-toxic, antimicrobial electrolyzed saline solution exhibiting anti-infective and immune-enhancing potential as a therapeutic containing regulated amounts of stable reactive oxygen species (ROS) according to claim 3 , wherein the anode has a cylindrical, or flat (planar) shaped structure.

5. An apparatus for producing a stable, non-toxic, antimicrobial electrolyzed saline solution exhibiting anti-infective and immune-enhancing potential as a therapeutic containing regulated amounts of stable reactive oxygen species (ROS) according to claim 4 , wherein the cathode has a cylindrical, or flat (planar) shaped structure and is positioned coaxially or in parallel in relation to the anode.

6. An apparatus for producing a stable, non-toxic, antimicrobial electrolyzed saline solution exhibiting anti-infective and immune-enhancing potential as a therapeutic containing regulated amounts of stable reactive oxygen species (ROS) according to claim 5 , wherein the cathode is made of a base metal selected from the group consisting of platinum, niobium, titanium or any metal compatible with platinum bonding and is plated with an outer layer of platinum bonded to the base metal.

7. An apparatus for producing a stable, non-toxic, antimicrobial electrolyzed saline solution exhibiting anti-infective and immune-enhancing potential as a therapeutic containing regulated amounts of stable reactive oxygen species (ROS) according to claim 1 , wherein the spacing between the cathode and the anode is less than one inch and is dependent upon ion transfer rates and electric fields to achieve desired electrolysis efficiencies to produce different varieties of solution components all containing stable ROS compounds.

8. An apparatus for producing a stable electrolyzed saline solution for treating a human or warm-blooded animal, comprising:

a) a container filled with a saline solution having a concentration between about 0.15% and about 1.0% by weight, the container comprising a single exterior opening that is fitted with a lid;

b) a permeable inert anode and a permeable inert cathode placed within the container associated with a power source configured to apply an effective voltage potential less than about thirty volts between the cathode and the anode to electrolyze the saline solution and produce a first target mixture of chemically reduced and oxidized molecules;

c) a combination heating/cooling device disposed coaxially along an interior side of the container configured to exchange heat with the saline solution to maintain the saline solution at a desired temperature between 30° F. and 100° F. during electrolysis to prevent production of chlorates and to regulate relative concentrations of resulting components during electrolysis; and

d) two exteriorly mounted circulation tubes, each circulation tube in fluid communication with a top and a bottom interior of the container and configured with a pump to provide fluid circulation within the container,

wherein the structure and flow pattern of the two exteriorly mounted circulation tubes ensure complete mixing and electrolysis of the saline solution to produce ROS concentrations between about 0.05 ppm and 50 ppm with a variation of less than 5% from batch to batch,

wherein the first target mixture is configured to mirror a second target mixture of chemically reduced and oxidized molecules, the second target mixture corresponding to a biological system.

9. The apparatus of claim 8 , wherein the first target mixture and the second target mixture are measured using a fluorospectrometer configured to measure concentrations of reactive oxygen species.

10. The apparatus of claim 9 , wherein the concentrations are measured using at least one fluorescent dye selected from R-phycoerytherin, hydroxyphenyl fluorescein, and aminophenyl fluorescein.

11. The apparatus of claim 8 , wherein the first target mixture of chemically reduced and oxidized molecules comprises one or more of HOCl, OCl − , NaClO, O 2 , Cl 2 , H 2 , H 2 O 2 , H + , ClO, *O 2 —, HO 2 , O 3 , H − , Cl − , NaOH, OH − , *O 2 , *OCl, or *HO − .

12. The apparatus of claim 8 , wherein the container is fabricated from a biologically compatible material.

13. The apparatus of claim 8 , wherein the anode is made of a base metal selected from platinum, niobium, titanium, a combination thereof, or any metal compatible with platinum bonding and is coated with an outer layer of platinum.

14. The apparatus of claim 8 , wherein the anode has a cylindrical or flat shaped structure.

15. The apparatus of claim 8 , wherein the cathode has a cylindrical or flat shaped structure.

16. The apparatus of claim 8 , wherein the cathode is made of a base metal selected from platinum, niobium, titanium, a combination thereof, or any metal compatible with platinum bonding, and is plated with an outer layer of platinum.

17. The apparatus of claim 8 , wherein a space between the cathode and the anode is less than one inch.

18. The apparatus of claim 17 , wherein the space is dependent upon ion transfer rates and electric fields.

Assignments (2)
CHANGE OF NAME Recorded Jun 18, 2019
From: REOXCYN DISCOVERIES GROUP, INC.
To: RDG HOLDINGS, INC.
Reel/Frame 049511/0685 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 15, 2013
From: NORTON, VERDIS; SAMUELSON, GARY L.
To: REOXCYN DISCOVERIES GROUP, INC.
Reel/Frame 029820/0056 →
Continuity (4)
Division 12383212 · Mar 20, 2009
Continuation In Part 12290398 · Oct 30, 2008
Provisional Application 61001010 · Oct 30, 2007
Related Publication 20130092531A1 · Apr 18, 2013